510(k) K911362
K911362 is an FDA 510(k) premarket notification submitted by Amico Laboratories, Inc. for the device "AMIZYME EPSTEIN-BARR VIRUS (EBV) IGM ANTIBODY TEST". The FDA issued a decision of Substantially Equivalent on Oct 7, 1991. The device falls under product code LJN (Antibody Igm, If, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 7, 1991
- Date Received
- Mar 28, 1991
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibody Igm, If, Epstein-Barr Virus
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Amico Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.